Stopping GLP-1 medication is not acutely dangerous for most people
Clarkson and her team have also explored how brain activity differs between women who do and dont respond to treatment with botulinum toxin and pelvic floor muscle therapy, and they are currently investigating whether taking commonly prescribed bladder medications results in changes to the brain
Furthermore, most studies are limited to daily sampling and thus were not designed to address rapid changes that may occur within the endogenous metabolome of the individual in response to high-dose ingestion of APAP
Harnessing artificial intelligence to predict ovarian stimulation outcomes in in vitro fertilization: scoping review
At present, this recommendation includes subcutaneous semaglutide but does not yet include oral semaglutide [15, 17]
December 15, 2025: Study Shows that Zepbound May Not Reduce the Risk of Obesity-Related Cancers Earlier this year, researchers suggested that Zepbound, which many people take to lose weight, could lower someones risk of thirteen different obesity-related cancers